Menu
Logo

Patient journey



Optimising the patient journey


Find out how improved diagnosis could lead to improved prognosis.


Patient journey

Individuals diagnosed with AL amyloidosis have a wide range of experiences. Take a look at this hypothetical journey of a patient, and then see the potential impact improved awareness and cross-disciplinary collaboration could have made.


A patient with AL amyloidosis

ig-current-patient-journey

2+ YEARS TO IDENTIFY


which impacts both morbidity and mortality[1]

NT-proBNP=N-terminal pro-B-type natriuretic peptide

Working together for improved prognosis

What are the current treatments and techniques to manage patients with AL amyloidosis? In this short 4-minute video, Dr Vaishali Sanchorawala (haematology/oncology) and Dr Omar Siddiqi (cardiology) discuss the importance of multidisciplinary collaboration in the decision-making process in order to transform AL amyloidosis into a manageable chronic condition.

Learn about AL amyloidosis
Learn about the steps involved in diagnosing patients with AL amyloidosis

Download this information on AL amyloidosis

CP-255639 - September 2021